Trajectory-Image 2 (1)

Company Milestones

Every Step Counts

We are proud of the milestones we have accomplished since our founding in 2016. Each step forward is a step closer to our goal to improve healthcare through better disease detection.


Billion To One was founded

2016 – 2017

Received $2.5M seed funding (Y Combinator and others)


Rented half of a bench at Start X

September 2018

Received a National Institutes of Health grant for the first single-gene NIPT (sgNIPT) clinical study with Baylor University

Jan 2019

Moved to the first non-shared lab with six employees

March 2019

Closed series A funding ($15M)

June 2019

Achieved Clinical Laboratory Improvement Amendments (CLIA) certification

July 2019

Received the first UNITY commercial sample

October 2019

Published first sgNIPT validation study in Nature Scientific Reports

July 2020

Launched UNITY aneuploidy and RhD tests

February 2021

Closed series B funding ($55M)

April 2021

Moved into lab 2.0

March 2022

Closed series C funding ($125M)

April 2022

Published sgNIPT health economics study in Journal of Health Economics

April 2022

Hired 200th employee

May 2022

Achieved College of American Pathologists (CAP) Lab Accreditation Program Certification

May 2022

Published sgNIPT sickle cell disease data in the American Journal of Hematology

June 2022

Liquid biopsy research product available